Literature DB >> 26904434

Minimally invasive radical thymectomy.

Gopal Singh1, Jason Glotzbach1, Joseph Costa1, Lyall Gorenstein1, Mark Ginsburg1, Joshua R Sonett1.   

Abstract

Year:  2016        PMID： 26904434      PMCID： PMC4740104          DOI： 10.3978/j.issn.2225-319X.2015.09.01

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  5 in total

1.  Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis.

Authors:  R Scelsi; M T Ferrò; L Scelsi; L Novellino; R Mantegazza; F Cornelio; M Porta; C Longoni; G Pezzuoli
Journal:  Int Surg       Date:  1996 Jan-Mar

2.  "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique.

Authors:  A Jaretzki; M Wolff
Journal:  J Thorac Cardiovasc Surg       Date:  1988-11       Impact factor: 5.209

3.  Thymectomy for myasthenia gravis in children: a comparison of open and thoracoscopic approaches.

Authors:  Seth D Goldstein; Nicholas T Culbertson; Deiadra Garrett; Jose H Salazar; Kyle Van Arendonk; Kimberly McIltrot; Michelle Felix; Fizan Abdullah; Thomas Crawford; Paul Colombani
Journal:  J Pediatr Surg       Date:  2014-10-30       Impact factor: 2.545

4.  Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients.

Authors:  Julissa Jurado; Jeffrey Javidfar; Alexis Newmark; Matt Lavelle; Matthew Bacchetta; Lyall Gorenstein; Frank D'Ovidio; Mark E Ginsburg; Joshua R Sonett
Journal:  Ann Thorac Surg       Date:  2012-06-28       Impact factor: 4.330

Review 5.  Thymectomy in the management of myasthenia gravis.

Authors:  Alfred Jaretzki; Kenneth M Steinglass; Joshua R Sonett
Journal:  Semin Neurol       Date:  2004-03       Impact factor: 3.420
  5 in total
  1 in total

1.  Prognostic predictors of remission in ocular myasthenia after thymectomy.

Authors:  Xiang Liu; Wangyan Zhou; Jun Hu; Mingsong Hu; Wenkui Gao; Shan Zhang; Wei Zeng
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.